-
Sun Pharma Ends Day at Rs 1506.55, Trades 1.79M Shares with 7-Day Avg Volume of 4.37M
April 29th 2024 11:36PM
Sun Pharmaceutical Industries concluded the previous trading day at a closing price of Rs 1506.55, w...
-
Greece's leap in advancing pharmaceutical research | eKathimerini.com
April 29th 2024 11:17PM
Greece aims to become a hub for pharmaceutical research and drug production in Europe. The investmen...
-
X4 Pharmaceutical's Immunodeficiency Disease Therapy gets FDA Approval - Medriva
April 29th 2024 10:45PM
X4 Pharmaceuticals announced on Monday, April 29, 2024, that it has received FDA approval in the Uni...
-
Sun Pharma Stock Sees Modest Gain Today Amid Month-Long Decline
April 29th 2024 10:41PM
Sun Pharmaceutical Industries is currently trading at Rs 1523.95, marking a 1.16% increase for the d...
-
Sun Pharma's Stock Sees Marginal Increase with 1.02% Rise, 1-Day Returns at -0.89%
April 29th 2024 10:02PM
Sun Pharmaceutical Industries is currently trading at a price of Rs 1521.9, showing a 1.02% increase...
-
UK Launches Circularity in Primary Pharmaceutical Packaging Accelerator Initiative to ...
April 29th 2024 9:05PM
The non-profit initiative puts collaboration at the forefront as it tackles the challenges surroundi...
-
Teva Pharmaceutical (TEVA) Receives a Buy from Piper Sandler | Markets Insider
April 29th 2024 8:37PM
Piper Sandler analyst David Amsellem reiterated a Buy rating on Teva Pharmaceutical (TEVA – Resear...
-
Long road ahead for EU Pharma Package says Polish pharmaceutical sector - Euractiv
April 29th 2024 8:34PM
Poland's pharmaceutical industry says there's still a long journey ahead for the revision of...
-
Sun Pharma's Stock Sees Modest Gain, Trading Volume Slightly Below Average
April 29th 2024 8:33PM
Sun Pharmaceutical Industries is currently trading at a price of Rs 1521.0, reflecting a 0.96% incre...
-
Teva Pharmaceutical (TEVA), Healthcare Services (HCSG) and ImmunityBio (IBRX) | Markets Insider
April 29th 2024 8:21PM
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Teva Pharmaceutica...
-
Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion
April 29th 2024 7:57PM
Deciphera Shareholders to Receive $25.60 per Share in Cash....
-
Sun Pharma Stock Sees Incremental Rise, 6-Month Returns Stand Strong at 36.5%
April 29th 2024 7:37PM
Sun Pharmaceutical Industries is currently trading at a price of Rs 1519.85, showing a modest increa...
-
Ono Pharmaceutical acquires Deciphera Pharmaceuticals for $2.4B
April 29th 2024 7:32PM
The $2.4 billion deal will bring Deciphera's cancer drugs Qinlock, vimseltinib and DCC-3116 unde...
-
Indian pharmaceutical industry set for major transformation: Dilip Shanghvi
April 29th 2024 7:32PM
At an annual meeting of the USA-India Chamber of Commerce in Boston, Shanghvi told a gathering of le...
-
Collegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA Inc ...
April 29th 2024 6:57PM
(Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the l...
-
Ono Pharmaceutical acquires cancer-focused biopharma Deciphera for $2.4bn
April 29th 2024 5:17PM
Deciphera Pharmaceuticals is set to be acquired in a $2.4bn buyout, as the biopharma announced that ...
-
Government is 'placing pharmaceutical profits over lives' in pandemic treaty talks, campaigners warn
April 29th 2024 4:38PM
“If we are truly to learn the lessons of the Covid-19 pandemic, we must ensure we never again allo...
-
Writing for pleasure or pain? - The Pharmaceutical Journal
April 29th 2024 4:33PM
This month's pick of academic papers from Parastou Donyai, chief pharmacist at the Royal Pharmac...
-
Global Production of Active Pharmaceutical Ingredients for US Generic Drugs Experiencing ...
April 29th 2024 3:59PM
This study evaluates the characteristics of generic active pharmaceutical ingredients (APIs) used to...
-
Global Active Pharmaceutical Ingredients Market Analysis Report 2024-2030: Synthetic API ...
April 29th 2024 3:39PM
The market is driven by the growth of the biopharmaceutical sector, advancements in active pharmaceu...
-
Services